Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia

Parasites and Vectors

Volumn 6, Issue 1, 2013, Pages

  Walle, Fisseha ^a   Kebede, Nigatu ^b,c   Tsegaye, Aster ^b   Kassa, Tesfu ^b  

^a Bahir Dar Regional Health Research Laboratory   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

HIV; IgG; IgM; Seroprevalence; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; CAT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; FOOD INTAKE; HEALTH EDUCATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RAW MEAT; READING; RESIDENTIAL AREA; SEROPREVALENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS; AGED; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; PARASITOLOGY; PREVALENCE; RISK FACTOR; TOXOPLASMA;

COCCIDIA; PROTOZOA; TOXOPLASMA GONDII;

ADULT; AGED; ANTIBODIES, PROTOZOAN; CROSS-SECTIONAL STUDIES; ETHIOPIA; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84872178718     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-6-15     Document Type: Article

References (47)

1. Toxoplasma gondii: from animals to humans. Tenter AM, Heckeroth AR, Weiss LM, Int J Parasitol 2000 30 1217 1258 10.1016/S0020-7519(00)00124-7 11113252
2. Toxoplasmosis and immune suppression. Djurković-Djaković O, Srp Arh Celok Lek 1998 126 5-6 197 203 9863381
3. Seroprevalence of Toxoplasma gondii in Nazareth town Ethiopia. Negash T, Tilahun G, Medhin G, East Afr J Public Health 2008 5 3 211 214 19374326
4. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Denkers YE, Gazzinelli TR, Clin Microbiol Rev 1998 11 4 569 588 9767056
5. Some aspects of protozoan infections in immuno compromised patients-a review. Ferreira SM, Borges SA, BioLine Int System 2002 97 4 443 457
6. Seroprevalence of Toxoplasma gondii infection amongst residents of tanga district in north-east Tanzania. Swai ES, Schoonman L, Tanz J Hth Res 2009 11 4 205 209
7. Seroprevalence of Toxoplasma gondii antibodies in a healthy population from Slovakia. Studeničová C, Benčaiová G, Holková R, Eur J Intern Med 2006 17 470 473 10.1016/j.ejim.2006.07.007 17098589 (Pubitemid 44708738)
8. Toxoplasma gondii infection in the united states: seroprevalence and risk factors. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB, Am J Epidemiol 2001 154 357 365 10.1093/aje/154.4.357 11495859 (Pubitemid 32756632)
9. Toxoplasmosis in panama: a 10-year study. Sousa OE, Saenz RE, Frenkel JK, AmJTrop Med Hyg 1988 38 315 322 (Pubitemid 18086112)
10. Toxoplasmosis. Dubey JP, J Am Vet Med Assoc 1994 205 1593 1598 7730132 (Pubitemid 24367495)
11. Sero epidemiology of toxoplasmosis in high-school students in the metropolitan area of Guadalajara, Jalisco, Mexico. Galvan Ramirez ML, Rodríguez Pérez LR, Ledesma Agraz SY, Sifuentes ávila LM, Armenta Ruíz AS, Corella DB, Ramírez Fernández BJ, Sanromán RT, Sci Med 2010 20 1 59 63
12. Toxoplasmosis. Lynfield R, Guerina NG, Ped Rev 1997 18 75 83 10.1542/pir.18-3-75
13. Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt. Elsheikha MH, Azab SM, Abousamra KN, Rahbar HM, Elghannam MD, Raafat D, J Parasitol 2009 104 6 1471 1476 10.1007/s00436-009-1350-z
14. Antigenaemia and antibody response to toxoplasma gondii in human immuno deficiency virus infected patients. Malla N, Sengupta C, Dubey ML, Sud A, Dutta U, Br J Biomed Sci 2005 28 104 109
15. Epidemiological findings and prevalence of Toxoplasma gondii antibodies in HIV-positive patients in a Venezuelan hospital. Martinez E, Mago H, Rocha R, Pacheco M, Valencia Int Conf AIDS 2002 7-12 14
16. Cerebral toxoplasmosis in adult patients with HIV infection. Jayawardena S, Singh S, Burzyantseva O, Clarke H, Clin Med J Resid Hosp Physician 2008 44 7 17 24
17. Seroepidemiology of toxoplasmosis among HIV- infected patients and healthy blood donors. Nissapatorn V, Kamarulzaman A, Init I, Tan LH, Rohela M, Norliza A, Chan LL, Latt HM, Anuar AK, Quek KF, Med J Malaysia 2002 57 3 304 310 12440270 (Pubitemid 35439983)
18. Toxoplasma gondii. Montoya JG, Remington JS, Principles and practice of infectious diseases Odon: Churchill Livingstone, Mandell GE, Beneth JE, Dolin R, 5 2000 2858 2888
19. Parasitic central nervous system infections in immunocompromised hosts. Walker M, Zunt JR, Clin Inf Dis 2005 40 1005 1015 10.1086/428621 (Pubitemid 40418309)
20. Recommendation for diagnostics and therapy of toxoplasmosis in persons with HIV infection. Machala L, Kodym P, Rozsypal H, Stanková M, Sedlácek D, Klin Mikrobiol Infekc Lek 2007 13 248 252 18320505
21. UNAIDS, UNAIDS: world AIDS Day report, 2011 Ethiopia: Impact of HIV/AIDS 2011 http://www.etharc.org/oromia/resources/kit/ARTInfotoolkit.pdf. Accessed on June 24, 2012
22. Central Statistical Authority of Ethiopia (CSA), Summary and statistical report of the 2007 population census. Population size by age and sex Federal Democratic Republic of Ethiopia: Population census Commission 2008
23. Federal Ministry of Health (FMOH), Guidelines for management of opportunistic infections and anti retroviral treatment in adolescents and adults in Ethiopia Office Federal Ministry of Health: Federal HIV/AIDS Prevention and Control 2008
24. Review on human toxoplasmosis in Malaysia: the past, present and prospective future southeast Asian. Nissapatorn V, Abdullah AK, J Trop Med Public Health 2004 35 1 24 30 (Pubitemid 38860053)
25. Seroprevalence of latent Toxoplasma gondii infection among HIV- infected and HIV-uninfected people in Addis Ababa Ethiopia: a comparative cross-sectional study. Shimelis T, Tebeje M, Tadesse E, Tegbaru B, Terefe A, Pak J Biol Sci 2009 published online October 23
26. Prevalence of anti-toxoplasma antibodies in patients with acquired immunodeficiency syndrome and blood donors in bamako. Maïga I, Kiemtoré P, Tounkara A, Bull Soc Pathol Exot 2001 94 3 268 270 11681225
27. Pattern of demographic risk factors in the seroprevalence of anti-Toxoplasma gondii antibodies in HIV infected patients at Lagos university teaching hospital. Akanmu AS, Asunkalu VO, Ofomah JN, Olowosenlu FO, Nig Q J Hosp Med 2010 20 1 1 4 20450022
28. Toxoplasma gondii infection in humans in china. Zhou P, Chen Z, Li HL, Zheng H, He S, Lin RQ, Zhu XQ, Parasit Vectors 2011 4 165 10.1186/1756-3305-4- 165 21864327
29. Evaluation of the elke latex agglutination test for anti-Toxoplasma antibodies and seroprevalence of Toxoplasma infection among factory workers in Addis Ababa Ethiopia. Woldemichael T, Fontanet AL, Sahlu T, Gilis H, Messele T, Yeneneh H, Coutinho RA, Van Gool T, Trans R Soc Trop Med Hyg 1998 92 4 401 403 10.1016/S0035-9203(98)91065-3 9850391 (Pubitemid 28409884)
30. Reduced risk of Toxoplasma encephalitis in HIV-infected patients-a prospective study from Gauteng, south Africa. Hari KR, Modi MR, Mochan AHD, Modi G, Int J STD AIDS 2007 18 8 555 558 10.1258/095646207781439829 17686219 (Pubitemid 351738945)
31. Toxoplasmosis in HIV/AIDs patients in Iran. Davarpanah MA, Mehrabani D, Neirami R, Ghahremanpoor M, Darvishi M, Iran Red Crescent Med J 2007 9 1 22 27
32. High seroprevalence of Toxoplasma gondii infection in a subset of Mexican patients with work accidents and low socioeconomic status. Alvarado-Esquivel C, Torres-Castorena A, Liesenfeld O, Estrada-Martínez S, Urbina-álvarez JD, Parasit Vectors 2012 5 13 10.1186/1756-3305-5-13 22236539
33. Antibodies against Toxoplasma gondii in patients with HIV in Yucatan. Góngora-Biachi RA, Gonzalez Martinez P, Castro-Sansores C, Alvarez-Moguel R, Pavía-Ruz N, Lara-Perera D, Alonzo-Salomón G, Palacios-Pérez E, Rev Invest Clin 1998 50 5 419 22 9949673
34. Prevalence of IgM and IgG antibodies to Toxoplasma gondii in blood donors at the Czech republic. Svobodová V, Literák I, Eur J Epidemiol 1998 14 8 803 805 10.1023/A:1007589422080 9928876 (Pubitemid 29038342)
35. Seroepidemiology of infection with Toxoplasma gondii in health blood donors of Durango, Mexico. Alvarado-Esquivel C, Mercado-Suarez FM, Rodringuez-Briones A, Fallad-Torres L, Ayala-Ayala OJ, Nevarez-Piedra JL, Duran-Morales E, Estrada-Martinez S, Liessenfeld O, Marquez AJ, BMC Infect Dis 2007 7 75 10.1186/1471-2334-7-75 17629901 (Pubitemid 47244207)
36. Prevalence of IgG antibodies specific to Toxoplasma gondii among blood donors in Recife northeast brazil. Coelho RA, Kobayashi M, Carvalho J, Rev Inst Med Trop Sao Paulo 2003 45 4 229 231 14502353 (Pubitemid 37107962)
37. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in aydi province turkey. Ertug S, Okyay P, Turkmen M, Yuksel H, BMC Publ Health 2005 5 66 10.1186/1471-2458-5-66 (Pubitemid 41096320)
38. Toxoplasma gondii serology in HIV infected patients: the development of central nervous system toxoplasmosis in AIDS. Grant IH, Gold WM, Rosenblum M, Niedzwieki D, Armstrong D, AIDS 1990 4 519 521 10.1097/00002030-199006000-00004 2386617 (Pubitemid 20215021)
39. Cats and toxoplasmosis risk in HIV-infected adults. Wallace MR, Rossetti RJ, Olson PE, JAMA 1993 269 1 76 7 10.1001/jama.1993.03500010086037 8416410 (Pubitemid 23006527)
40. Toxoplasmosis at the Pasteur institute of Bangui, central African republic (1996-1998): serological data. Morvan JM, Mambely R, Selekon B, Coumanzi-Malo MF, Bull Soc Pathol Exot 1999 92 157 160 10472439
41. A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population. Galván-Ramírez ML, Troyo R, Roman S, Calvillo-Sanchez C, Bernal-Redondo R, Gómez F, Parasit Vectors 2012 5 271 10.1186/1756-3305-5-271 23181616
42. Toxoplasmic antibodies in sera of HIV-infected persons. Sýkora J, Zástra M, Stanková M, Folia Parasitol (Praha) 1992 39 177 180
43. Extracerebral toxoplasmosis in patients infected with HIV. A French national survey. Rabaud C, May T, Amiel C, Katlama C, Leport C, Ambroise-Thomas P, Canton P, Medicine (Baltimore) 1994 73 306
44. Preliminary report of HIV and Toxoplasma gondii occurrence in pregnant women from Mozambique. Sitoe SP, Rafael B, Meireles LR, Andrade HF, Thompson R, Rev Inst Med Trop Sao Paulo 2010 52 6 291 2295 21225211
45. Toxoplasma gondii: an AIDS enhancing cofactor. Lin DS, Bowman DD, Medical Hypotheses 1992 39 2 140 142 10.1016/0306-9877(92)90174-B 1334211
46. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Fleger J, Kova S, Kodym P, Frgnta O, Parasitol 1996 113 49 54 10.1017/S0031182000066269 (Pubitemid 26228367)
47. Sero-prevalence of latent Toxoplasma gondii infection among HIV-infected and HIV-uninfected people in Addis Ababa Ethiopia: a comparative cross-sectional study. Shimelis T, Tebeje M, Tadesse E, Tegbaru B, Terefe A, BMC Res Notes 2009 2 213 10.1186/1756-0500-2-213 19852805